NCT05838131View on ClinicalTrials.gov

Study of CT071 Injection in RRMM or PPCL

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 28, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Multiple MyelomaPrimary Plasma Cell Leukemia
Interventions
DRUG

Experimental: CAR-T cells Infusion

"Biological:~chimeric antigen receptor T cells"

Trial Locations (1)

Unknown

Shanghai Changzheng Hospital, Shanghai

Sponsors
All Listed Sponsors
collaborator

CARsgen Therapeutics Co., Ltd.

INDUSTRY

lead

Shanghai Changzheng Hospital

OTHER